Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Janus kinase inhibitors may help treat lichen planopilaris.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

N-acetylcysteine and ImuVert can prevent hair loss in rats caused by chemotherapy.

PLD is an effective and safer alternative for treating breast cancer.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Baricitinib helps regrow hair in teens with severe alopecia areata.

The compound 4c showed strong potential as an anticancer agent.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Thymic LCH may be underdiagnosed, so thymic ultrasound should be considered in infants with cutaneous LCH.

Baricitinib may help people with long-term alopecia areata.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.